BACKGROUND AND OBJECTIVES: Passive and active immunity transfer through human milk (HM) constitutes a key element in the infant's developing immunity. Certain infectious diseases and vaccines have been described to induce changes in the immune components of HM. METHODS: We conducted a prospective cohort single-institution study from February 2 to April 4, 2021. Women who reported to be breastfeeding at the time of their coronavirus disease 2019 (COVID-19) vaccination were invited to participate. Blood and milk samples were collected on day 14 after their second dose of the vaccine. Immunoglobulin G (IgG) antibodies against nucleocapsid protein as well as IgG, immunoglobulin M and immunoglobulin A (IgA) antibodies against the spike 1 protein receptor-binding domain against severe acute respiratory syndrome coronavirus 2 (anti-SARS-CoV-2 RBD-S1) were analyzed in both serum and HM samples. RESULTS: Most of the participants (ie, 94%) received the BNT162b2 messenger RNA COVID-19 vaccine. The mean serum concentration of anti-SARS-CoV-2 RBD-S-IgG antibodies in vaccinated individuals was 3379.6 ± 1639.5 binding antibody units per mL. All vaccinated study participants had anti-SARS-CoV-2 RBD-S1-IgG, and 89% of them had anti-SARS-CoV-2 RBD-S-IgA in their milk. The antibody concentrations in the milk of mothers who were breastfeeding 24 months were significantly higher than in mothers with breastfeeding periods <24 months (P < .001). CONCLUSIONS: We found a clear association between COVID-19 vaccination and specific immunoglobulin concentrations in HM. This effect was more pronounced when lactation periods exceeded 23 months. The influence of the lactation period on immunoglobulins was specific and independent of other variables.
BACKGROUND AND OBJECTIVES: Passive and active immunity transfer through human milk (HM) constitutes a key element in the infant's developing immunity. Certain infectious diseases and vaccines have been described to induce changes in the immune components of HM. METHODS: We conducted a prospective cohort single-institution study from February 2 to April 4, 2021. Women who reported to be breastfeeding at the time of their coronavirus disease 2019 (COVID-19) vaccination were invited to participate. Blood and milk samples were collected on day 14 after their second dose of the vaccine. Immunoglobulin G (IgG) antibodies against nucleocapsid protein as well as IgG, immunoglobulin M and immunoglobulin A (IgA) antibodies against the spike 1 protein receptor-binding domain against severe acute respiratory syndrome coronavirus 2 (anti-SARS-CoV-2 RBD-S1) were analyzed in both serum and HM samples. RESULTS: Most of the participants (ie, 94%) received the BNT162b2 messenger RNA COVID-19 vaccine. The mean serum concentration of anti-SARS-CoV-2 RBD-S-IgG antibodies in vaccinated individuals was 3379.6 ± 1639.5 binding antibody units per mL. All vaccinated study participants had anti-SARS-CoV-2 RBD-S1-IgG, and 89% of them had anti-SARS-CoV-2 RBD-S-IgA in their milk. The antibody concentrations in the milk of mothers who were breastfeeding 24 months were significantly higher than in mothers with breastfeeding periods <24 months (P < .001). CONCLUSIONS: We found a clear association between COVID-19 vaccination and specific immunoglobulin concentrations in HM. This effect was more pronounced when lactation periods exceeded 23 months. The influence of the lactation period on immunoglobulins was specific and independent of other variables.
Authors: Hannah G Juncker; Eliza J M Ruhé; Aniko Korosi; Johannes B van Goudoever; Marit J van Gils; Britt J van Keulen Journal: Front Nutr Date: 2022-06-30
Authors: Bahaa Abu-Raya; Shabir A Madhi; Saad B Omer; Gayatri Amirthalingam; Michelle L Giles; Katie L Flanagan; Petra Zimmermann; Miguel O'Ryan; Marco A Safadi; Vassiliki Papaevangelou; Kirsten Maertens; Nasamon Wanlapakorn; Vicens Diaz-Brito; Eline Tommelein; Susanna Esposito Journal: Front Immunol Date: 2021-12-23 Impact factor: 7.561
Authors: Ryan M Pace; Janet E Williams; Kirsi M Järvinen; Courtney L Meehan; Melanie A Martin; Sylvia H Ley; Celestina Barbosa-Leiker; Aline Andres; Laxmi Yeruva; Mandy B Belfort; Beatrice Caffé; Alexandra D Navarrete; Kimberly A Lackey; Christina D W Pace; Alexandra C Gogel; Bethaney D Fehrenkamp; Miranda Klein; Bridget E Young; Casey Rosen-Carole; Nichole Diaz; Stephanie L Gaw; Valerie Flaherman; Mark A McGuire; Michelle K McGuire; Antti E Seppo Journal: Front Immunol Date: 2021-12-23 Impact factor: 7.561
Authors: Yarden Golan; Mary Prahl; Arianna G Cassidy; Caryl Gay; Alan H B Wu; Unurzul Jigmeddagva; Christine Y Lin; Veronica J Gonzalez; Emilia Basilio; Megan A Chidboy; Lakshmi Warrier; Sirirak Buarpung; Lin Li; Amy P Murtha; Ifeyinwa V Asiodu; Nadav Ahituv; Valerie J Flaherman; Stephanie L Gaw Journal: Front Immunol Date: 2021-11-03 Impact factor: 7.561
Authors: Charlotte V Hobbs; Kate Woodworth; Cameron C Young; Ashley M Jackson; Margaret M Newhams; Heda Dapul; Mia Maamari; Mark W Hall; Aline B Maddux; Aalok R Singh; Jennifer E Schuster; Courtney M Rowan; Julie C Fitzgerald; Katherine Irby; Michele Kong; Elizabeth H Mack; Mary A Staat; Natalie Z Cvijanovich; Melania M Bembea; Bria M Coates; Natasha B Halasa; Tracie C Walker; Gwenn E McLaughlin; Christopher J Babbitt; Ryan A Nofziger; Laura L Loftis; Tamara T Bradford; Angela P Campbell; Manish M Patel; Adrienne G Randolph Journal: Pediatr Infect Dis J Date: 2022-03-01 Impact factor: 2.129